trending Market Intelligence /marketintelligence/en/news-insights/trending/XJZe-cyjWx_GJXJrXTqs1g2 content esgSubNav
In This List

Flex Pharma CEO to step down

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Flex Pharma CEO to step down

Flex Pharma Inc. said CEO Christoph Westphal will step down, effective July 3, and remain as board chairman.

The board appointed William McVicar, president of research and development, as interim CEO.